EC Number | Application | Comment | Organism |
---|---|---|---|
5.4.99.5 | drug development | fighting diseases such as tuberculosis. Since vertebrates lack the shikimate pathway for the biosynthesis of aromatic compounds and thus do not possess chorismate mutase activity, this enzyme represents a prime target for the development of antibiotics, fungicides and herbicides | Mycobacterium tuberculosis |
EC Number | Cloned (Comment) | Organism |
---|---|---|
5.4.99.5 | Escherichia coli strain KA29 | Mycobacterium tuberculosis |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
5.4.99.5 | 37.2 kDa. Each asymmetric unit contains a homodimer, corresponding to the two protomers of the biological dimer. *MtCM as a model system for the *AroQ subclass and determined its crystal structure at high resolution, both in its unliganded form and in complex with transition state analog (1S,3S,5R,6R)-6-hydroxy-4-oxabicyco[3.3.1]non-7-ene-1,3-dicarboxylic acid. Heavy-atom derivatives prepared. Successful heavy-atom compounds are lead (II) acetate and thallium (III) acetate | Mycobacterium tuberculosis |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
5.4.99.5 | (1S,3S,5R,6R)-6-hydroxy-4-oxabicyclo[3.3.1]non-7-ene-1,3-dicarboxylate | endo-oxabicyclic dicarboxylic acid is a good geometric mimic of transition state | Mycobacterium tuberculosis |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
5.4.99.5 | Chorismate | Mycobacterium tuberculosis | - |
Prephenate | - |
? | |
5.4.99.5 | Chorismate | Mycobacterium tuberculosis H37Rv | - |
Prephenate | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
5.4.99.5 | Mycobacterium tuberculosis | P9WIB9 | - |
- |
5.4.99.5 | Mycobacterium tuberculosis H37Rv | P9WIB9 | - |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
5.4.99.5 | *MtCM, which has a melting temperature of 48°C, rapidly renatures after heat denaturation, and have subsequently exploited this feature for purifying the enzyme | Mycobacterium tuberculosis |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
5.4.99.5 | Chorismate | - |
Mycobacterium tuberculosis | Prephenate | - |
? | |
5.4.99.5 | Chorismate | - |
Mycobacterium tuberculosis H37Rv | Prephenate | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
5.4.99.5 | dimer | Each assymmetric unit contains a homodimer, corresponding to the two protomers (A and B) of the biological dimer. The structure of a *MtCM protomer strongly resembles the fold of the EcCM dimer, which consists of two intertwined subunits of three helices each and which comprises two active sites | Mycobacterium tuberculosis |
5.4.99.5 | More | Ligand-induced structural changes are shown. Experiments neither show evidence for an equilibrium between the dimer and a *MtCM dimer of an intertwined nature, nor for an equilibrium with a monomer at lower protein concentrations as observed for engineered topology variants of chorismate mutases. The active site of *MtCM is highly similar to the catalytic sites of the other structurally characterized AroQ chorismate mutases | Mycobacterium tuberculosis |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
5.4.99.5 | chorismate mutase | - |
Mycobacterium tuberculosis |
5.4.99.5 | MtCM | - |
Mycobacterium tuberculosis |
EC Number | Temperature Stability Minimum [°C] | Temperature Stability Maximum [°C] | Comment | Organism |
---|---|---|---|---|
5.4.99.5 | additional information | - |
*MtCM melting temperature of 48°C | Mycobacterium tuberculosis |
EC Number | pH Minimum | pH Maximum | Comment | Organism |
---|---|---|---|---|
5.4.99.5 | 5 | 9 | the catalytic efficiency (kcat/Km) of *MtCM increases by two orders of magnitude upon decreasing the pH from 9 to 5 | Mycobacterium tuberculosis |